Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
168.4 USD | +0.59% | +2.06% | -6.70% |
May. 21 | Glenmark Pharma Arm to Market Two Beigene Cancer Drugs in India | MT |
May. 14 | BeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.70% | 17.51B | |
+10.15% | 114B | |
+12.70% | 107B | |
-5.46% | 22.22B | |
-0.67% | 21.28B | |
-4.64% | 18.8B | |
-39.36% | 17.17B | |
+6.94% | 14.14B | |
+34.15% | 12.2B | |
+15.10% | 8.01B |
- Stock Market
- Equities
- BGNE Stock
- News BeiGene, Ltd.
- Nomura Adjusts BeiGene's Price Target to HK$186.87 From HK$172.81, Keeps at Buy